ArticleJAMA oncology2023

Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial.

Tae Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.